Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry

American Heart Journal

Volumn 167, Issue 3, 2014, Pages

  O'Brien, Emily C ^a   Roe, Matthew T ^a   Fraulo, Elizabeth S ^a   Peterson, Eric D ^a   Ballantyne, Christie M ^b   Genest, Jacques ^c   Gidding, Samuel S ^d   Hammond, Emma ^e   Hemphill, Linda C ^f   Hudgins, Lisa C ^g   Kindt, Iris ^h   Moriarty, Patrick M ⁱ   Ross, Joyce ^h   Underberg, James A ^j   Watson, Karol ^k   Pickhardt, Dave ^h   Rader, Daniel J ^l   Wilemon, Katherine ^h   Knowles, Joshua W ^h,m  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^e DEPARTMENT OF HEALTH   (Australia)

^f HARVARD UNIVERSITY   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h FH Foundation   (United States)

ⁱ UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^j NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UCLA MEDICAL CENTER   (United States)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

^m STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DISEASE REGISTRY; ELECTRONIC MEDICAL RECORD; FAMILIAL HYPERCHOLESTEROLEMIA; HEALTH CARE SYSTEM; HUMAN; PRIORITY JOURNAL; SCREENING;

ELECTRONIC HEALTH RECORDS; FOUNDATIONS; HEALTH RECORDS, PERSONAL; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INTERNET; LONGITUDINAL STUDIES; MASS SCREENING; REGISTRIES; UNITED STATES;

EID: 84896696778     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.12.008     Document Type: Article

References (26)

1. J. Goldstein, and M. Brown Familial hypercholesterolaemia C. Scriver, A. Beudet, W. Sly, D. Valle, The metabolic basis of inherited disease 1995 McGraw Hill New York 1215 1245
2. R. Williams, I. Hamilton-Craig, and G. Kostner MEDPED: an integrated genetic strategy for preventing early deaths K. Berg, V. Boulyjenkov, Y. Christen, Genetic approaches to noncommunicable diseases 1996 Springer Verlag Berlin 35 46
3. H.A. Neil, T. Hammond, and R. Huxley et al. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study BMJ 321 7254 2000 148
4. M.A. Austin, C.M. Hutter, and R.L. Zimmern et al. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review Am J Epidemiol 160 5 2004 407 420
5. P.N. Hopkins, P.P. Toth, and C.M. Ballantyne et al. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 3 Suppl Jun 2011 S9 S17
6. United States Food and Drug Administration FDA approves juxtapid for homozygous familial hypercholesterolemia http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm333285.htm 2012
7. United States Food and Drug Administration FDA approves new orphan drug Kynamro to treat inherited cholesterol disorder http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm337195.htm 2013
8. A.C. Goldberg, P.N. Hopkins, and P.P. Toth et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 3 Suppl Jun 2011 S1 S8
9. J. Slack Risks of ischaemic heart disease in familial hyperlipoproteinaemic states Lancet 2 7635 1969 1380 1382
10. Steering Committee on behalf of the Simon Broome Register Group Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group BMJ 303 6807 1991 893 896
11. R.R. Williams, S.C. Hunt, and M.C. Schumacher et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics Am J Cardiol 72 2 1993 171 176
12. B.G. Nordestgaard, M.J. Chapman, and S.E. Humphries et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Eur Heart J 34 2013 3478 3490
13. J. Versmissen, D.M. Oosterveer, and M. Yazdanpanah et al. Efficacy of statins in familial hypercholesterolaemia: a long-term cohort study BMJ 337 2008 a2423
14. D. Bhatnagar, J. Morgan, and S. Siddiq et al. Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia BMJ 321 7275 2000 1497 1500
15. M.A. Umans-Eckenhausen, J.C. Defesche, and M.J. van Dam et al. Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia Arch Intern Med 163 1 2003 65 68
16. T.P. Leren, T. Manshaus, and U. Skovholt et al. Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program Semin Vasc Med 4 1 Feb 2004 75 85
17. Centers for Disease Control Office of Public Health Genomics Genomic tests by levels of evidence Updated April 15, 2013. http://www.cdc.gov/genomics/ gtesting/file/print/tier.pdf
18. D. Wonderling, M.A. Umans-Eckenhausen, and D. Marks et al. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in the Netherlands Semin Vasc Med 4 1 Feb 2004 97 104
19. M. Pocovi, F. Civeira, and R. Alonso et al. Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects Semin Vasc Med 4 1 Feb 2004 67 74
20. A.O. Orlova, M. Dunnagan, and T. Finitzo et al. Electronic health record-public health (EHR-PH) system prototype for interoperability in 21st century health care systems AMIA Annu Symp Proc 2005 575 579
21. M.A. Umans-Eckenhausen, J.C. Defesche, and E.J. Sijbrands et al. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands Lancet 357 9251 2001 165 168
22. R. Kehoe, S.Y. Wu, and M.C. Leske et al. Comparing self-reported and physician-reported medical history Am J Epidemiol 139 8 1994 813 818
23. L.M. Martin, M. Leff, and N. Calonge et al. Validation of self-reported chronic conditions and health services in a managed care population Am J Prev Med 18 3 Apr 2000 215 218
24. M.J. Khoury, R.J. Coates, and J.P. Evans Evidence-based classification of recommendations on use of genomic tests in clinical practice: dealing with insufficient evidence Genet Med 12 11 Nov 2010 680 683
25. A. Neil, J. Cooper, and J. Betteridge et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study Eur Heart J 29 21 Nov 2008 2625 2633
26. Patient Protection and Affordable Care Act, 42 U.S.C. § 18001 et seq. (2010).